PORTFOLIO
Portfolio
-
Galux -
NEXTGEN -
NOVELTY NOBILITY -
Noul -
NuVi labs -
NeuroXT -
Doctornow -
DAAN Biotherapeutics -
Dr.diary -
WSG -
D&D Pharmatech -
DeepCardio -
LaSemilla -
RiboTech -
LiveCell Instrument -
RevoSketch -
Regen Innopharm -
Lynk Solutec -
MasterMeditech -
malgeunaeil -
MEDIOGEN -
Meditrix -
MEDiFAB -
Medipixel -
BIORCHESTRA -
BEAMWORKS -
BREEZEBIO -
CELLEMEDY -
SKINGRAB -
SPACE F -
3D Medivision -
CdmoGen -
CMES Robotics -
SeaWith -
ARUM THERAPEUTICS -
IDIENCE -
IBEX Medical Systems -
iN Therapeutics -
ANTEROGEN -
ALDAVER -
AbClon -
SN BioScience -
SNVIA -
SL Therapeutics -
ATsense -
FNCTBIOTECH -
Exosome Plus -
NRISE -
ENCLONY -
elisiGen -
ELGEN THERAPEUTICS -
MxT Biotech -
MTHERA PHARMA -
Orum Therapeutics -
AUTOTAC Bio -
ONNURISTORE -
OnUs linkit -
Opticho -
Ubix Therapeutics -
Eutilex -
Illimis Therapeutics -
JD Bioscience -
Gencellmed -
GI Cell -
G2E -
G2GBIO -
CHARMACIST -
Kanaph Therapeutics -
CARUS Bio -
CasCure Therapeutics -
CARENATION -
KCell Biosciences -
Curaum -
KEYPRIME Research -
Txinno Bioscience -
T&R Biofab -
TNS -
PharmCADD -
Phantomics -
1ST Biotherapeutics -
Protium Science -
HysensBio -
Huons Meditech -
HUINNO -
Celloram -
Hyperfine Research -
PhAST -
Ranelagh
DAYLI PARTNERS
201, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Tel : +82-2-563-0890
Fax : +82-2-563-8787
E-mail : contact@dayli.partners
Copyright © 2024 DAYLI PARTNERS. ALL RIGHTS RESERVED